Back

Current evidence in inotropes and vasodilators for cardiogenic shock

20 March 2026 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New drugs for circulatory shock: from existing practice to ongoing trials in medical management of circulatory shock Acute Cardiac Care ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Rebecca Mathew

University of Ottawa Heart Institute, Ottawa (Canada)

4 More presentations in this session

Presentation thumbnail
Should we use levosimendan?
Professor A. Combes (Paris, FR)
Slides Video
Presentation thumbnail
Vasopressors beyond noradrenalin
Professor D. Morrow (Boston, US)
Slides Video
Presentation thumbnail
Novel agents in cardiogenic shock
Ms M. Padilla Lopez (Barcelona, ES)
Slides Video
Presentation thumbnail
New drugs for circulatory shock: from existing practice to ongoing trials in first-line management of circulatory shock - discussion
Video

Access the full session

Session thumbnail
New drugs for circulatory shock: from existing practice to ongoing trials in medical management of circulatory shock

The Event

Event poster

ESC Acute CardioVascular Care 2026

20 March - 21 March 2026
You may be interested in
thumbnail
Congress Presentation
Early pharmacological treatment in cardiogenic shock: vasodilators, vasopressors, or inotropes?
thumbnail
Congress Session
Cardiogenic shock: update 2024
thumbnail
Congress Session
State of the art: cardiogenic shock

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources